Follow
Karl Smith Byrne
Karl Smith Byrne
Cancer Epidemiology Unit, University of Oxford
Verified email at ndph.ox.ac.uk
Title
Cited by
Cited by
Year
GWAS identifies 14 loci for device-measured physical activity and sleep duration
A Doherty, K Smith-Byrne, T Ferreira, MV Holmes, C Holmes, SL Pulit, ...
Nature communications 9 (1), 5257, 2018
2932018
Systemic inflammation markers and cancer incidence in the UK Biobank
TH Nøst, K Alcala, I Urbarova, KS Byrne, F Guida, TM Sandanger, ...
European journal of epidemiology 36 (8), 841-848, 2021
1692021
Physical activity of UK adults with chronic disease: cross-sectional analysis of accelerometer-measured physical activity in 96 706 UK Biobank participants
DT Barker J, Smith Byrne K, Doherty A, Foster C, Rahimi K, Ramakrishnan R ...
International Journal of Epidemiology, 2019
1462019
Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction
L Kachuri, RE Graff, K Smith-Byrne, TJ Meyers, SR Rashkin, E Ziv, ...
Nature communications 11 (1), 6084, 2020
1212020
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with∼ 430 000 women
N Murphy, A Knuppel, N Papadimitriou, RM Martin, KK Tsilidis, ...
Annals of Oncology 31 (5), 641-649, 2020
1172020
Accelerometer measured physical activity and the incidence of cardiovascular disease: Evidence from the UK Biobank cohort study
R Ramakrishnan, A Doherty, K Smith-Byrne, K Rahimi, D Bennett, ...
PLoS medicine 18 (1), e1003487, 2021
1122021
Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins
F Guida, N Sun, LE Bantis, DC Muller, P Li, A Taguchi, D Dhillon, ...
JAMA oncology 4 (10), e182078-e182078, 2018
1052018
A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort
KL Terry, H Schock, RT Fortner, A Hüsing, RN Fichorova, HS Yamamoto, ...
Clinical Cancer Research 22 (18), 4664-4675, 2016
1042016
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
M Nazarzadeh, Z Bidel, D Canoy, E Copland, M Wamil, J Majert, ...
The Lancet 398 (10313), 1803-1810, 2021
872021
Systolic blood pressure and risk of valvular heart disease: a Mendelian randomization study
M Nazarzadeh, AC Pinho-Gomes, KS Byrne, D Canoy, F Raimondi, ...
JAMA cardiology 4 (8), 788-795, 2019
802019
Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence
S Moody, S Senkin, SMA Islam, J Wang, D Nasrollahzadeh, ...
Nature Genetics 53 (11), 1553-1563, 2021
772021
Circulating insulin-like growth factor-I concentrations and risk of 30 cancers: prospective analyses in UK Biobank
A Knuppel, GK Fensom, EL Watts, MJ Gunter, N Murphy, K Papier, ...
Cancer research 80 (18), 4014-4021, 2020
652020
Reallocation of time between device-measured movement behaviours and risk of incident cardiovascular disease
R Walmsley, S Chan, K Smith-Byrne, R Ramakrishnan, M Woodward, ...
British journal of sports medicine 56 (18), 1008-1017, 2022
542022
Circulating insulin‐like growth factor‐I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank
EL Watts, GK Fensom, K Smith Byrne, A Perez‐Cornago, NE Allen, ...
International journal of cancer 148 (9), 2274-2288, 2021
492021
Association between musculoskeletal pain at multiple sites and objectively measured physical activity and work capacity: results from UK Biobank study
F Pan, KS Byrne, R Ramakrishnan, M Ferreira, T Dwyer, G Jones
Journal of science and medicine in sport 22 (4), 444-449, 2019
362019
Self-reported and objectively measured physical activity in people with and without chronic heart failure: UK Biobank analysis
J O'Donnell, K Smith-Byrne, C Velardo, N Conrad, G Salimi-Khorshidi, ...
Open heart 7 (1), e001099, 2020
342020
Vasectomy and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
K Smith, JM Castaño, MD Chirlaque, H Lilja, A Agudo, E Ardanaz, ...
Journal of Clinical Oncology 35 (12), 1297, 2017
322017
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
EL Watts, A Perez‐Cornago, GK Fensom, K Smith‐Byrne, U Noor, ...
International journal of cancer 151 (7), 1033-1046, 2022
252022
Prospective identification of elevated circulating CDCP1 in patients years before onset of lung cancer
S Dagnino, B Bodinier, F Guida, K Smith-Byrne, D Petrovic, MD Whitaker, ...
Cancer research 81 (13), 3738-3748, 2021
232021
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian …
EL Watts, A Perez-Cornago, GK Fensom, K Smith-Byrne, U Noor, ...
International journal of epidemiology 52 (1), 71-86, 2023
222023
The system can't perform the operation now. Try again later.
Articles 1–20